Radiotherapy Induced Oral Mucositis Treatment Market is expected to reach a valuation of US$ 4.89 Billion by 2033 | FMI

The global Radiotherapy Induced Oral Mucositis Treatment Market is expected to generate a market value of US$ 3 billion in 2023 and a market value of US$ 4.89 billion by 2033, with a CAGR of 5% from 2023 to 2033. From 2018 to 2022, the market for Radiotherapy Induced Oral Mucositis Treatment grew at a …

Antibiotic Therapy to Procure 45% Market Share for Meningococcal Meningitis Treatment Market | FMI Study

According to Future Market Insights, the Meningococcal Meningitis Treatment Market is expected to grow at a 4.7% CAGR from 2023 to 2033. By the year 2033, the global market for Meningococcal meningitis treatment is expected to reach US$ 283 million. The increasing prevalence of the disease, the availability of vaccines, and the growing awareness of …

Kaempferol Market is anticipated to be valued at US$ 5.79 billion by 2032

[342 Pages Report] The kaempferol market, which was valued at US$ 3.91 billion in 2022, is expected to grow at a CAGR of 4% during the forecast period, reaching US$ 5.79 billion by 2032. Kaempferol provides excellent benefits like reducing the risk of chronic diseases like cancer, strengthening anti-oxidant defense against free radicals, offering resistance against …

Cancer Gene Therapy Market is expected to increase at a 10.1% CAGR from 2022 to 2032

[300+ Pages Report] As per Future Market Insights’ latest revised industry analysis, the global cancer gene therapy market is projected to expand at a 10.1% CAGR over the forecast period, with the market size reaching US$ 5.3 Bn in 2032. Gene therapy is a field of medicine that aims to cure or greatly improve the treatment of diseases that have few …

Teleradiology Services Market is predicted to grow at 19% CAGR by 2032

The global teleradiology services market demand is estimated to register a CAGR of 21.0% over the forecast period. The teleradiology services market is predicted to grow at 19% CAGR through 2032. The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of …

Dermatology Devices Market is expected to a CAGR rate of 6.5% by 2032

The market for dermatology devices was valued at US$ 4.6 billion in 2021 and is expected to grow at a CAGR of 6.5% to US$ 9.3 billion by the end of 2032. In 2021, Laser will dominate its product segment, with a market share of roughly 46.1%, according to a recent analysis by Future Market …

North America Vision Care Market is expected to be valued at US$ 100.72 Billion by 2026

The North America vision care market is projected to register a CAGR of 9.8% during the forecast period and is expected to be valued at US$ 100.72 Bn by the end of 2026. In this report, Future Market Insights analyses the factors and trends impacting the growth and performance of the North America vision care market. …

Prosthetic Heart Valve Market is projected to grow at a prolific CAGR of 11.4% by 2032

The Prosthetic Heart Valve Market was estimated at US$ 10.9 billion in 2021, and by the end of 2022, it is anticipated to reach US$ 12.3 billion. Because valvular disorders like aortic stenosis (AS), organic and ischemic (functional) mitral regurgitation, and tricuspid regurgitation are becoming more common, it is anticipated that worldwide demand for prosthetic …

Coronary Stents Market is expected to grow at a 5.1% CAGR

According to the most recent Future Market Insights (FMI) report, the demand for portable and coronary stents market will increase significantly over the next few years. The demand for interventional cardiology care is being fuelled by the rising prevalence of coronary artery disease. Angioplasty is the first choice of treatment for patients with long-term CAD. Over the …

Ultrasound-Guided Breast Biopsy Market is likely to register CAGR of 8% through 2032

The global ultrasound-guided breast biopsy market is anticipated to reach US$ 1,090 million by 2032, growing at an 8% CAGR during the forecast period. In 2022, the ultrasound-guided biopsy market is expected to be worth US$ 720 million. Over the projection period, the rising incidence of breast cancer cases and increased awareness about early detection …